Wuxi Biortus Biosciences

Expertise Partner

Biortus is a structure-based drug discovery CRO with a mature protein focused lead generation platform including modular services in protein production, assay development, fragment screening, and structure determination in microED, CryoEM, and X-ray crystallography. Coupling our dedicated membrane protein production group to cryoEM team, we developed an efficient structure generation pipeline. Our Boston site supports 2-way sample shipment and serves as the headquarters for our off-the-shelf Protein Catalogue which includes ion channels, GPCRs, and more.




Program Partner

leadXpro AG is a biotechnology company specialized in structure-based drug discovery for membrane proteins. To unlock these challenging targets, we bring together specialized knowledge in protein science, pioneering technologies in structural biology and expertise in ligand design and characterization. leadXpro’s research covers a range of membrane proteins, including GPCRs, ion channels and transporters. leadXpro acts as a research partner for a growing number of pharmaceutical, biotechnology and academic partners.




Innovation Partner

Based in Charleroi, Belgium, EuroscreenFast has been a pioneer in GPCR science for more than 30 years, offering a catalogue of over 1,000 functional assays representing more than 530 GPCR and other targets. EuroscreenFast also boasts an impressive deorphanisation track record with the identification of 17 natural receptor-ligand pairs, as well as one of the largest libraries of orphan GPCR cell lines. Custom cell line and assay development is another core offering.

Furthermore, EuroscreenFast has developed specialized assays to bridge the gap between in vitro and in vivo data. Therapeutic developers worldwide know that EuroscreenFast strategically design each program based on the latest knowledge of the target’s biology – EuroscreenFast is your unrivalled GPCR development partner.


Nanoimaging-e1676027511620 (1)[11]

NanoImaging Services

Exhibition Partner

Visualizing biomolecular structures through cryo-EM studies can provide insight into multiple stages of the drug development process, from target identification through manufacturing. As the industry leader in cryo-EM, with more cryo-EM scientists and TEM microscopes than any service provider in North America, NanoImaging Services is a CRO specializing in harnessing the power of cryo-EM to enable structure based drug design of a variety of targets including GPCRs, PROTAC, and molecular glue based complexes.


1. LCC Primary Logo Green Orange 1 (1)


Event Partner

LCC is an established chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs by expanding access to 3D chemical space.

LCC provide:

  • Access to 3D-rich, novel, enantiopure chemical space for use in an orthogonal hit-ID approach (FBLD, DEL, VLS etc)
  • 1.4 Billion member Ultra-Large Virtual Library and a representative physical 10,000 member HTS Enhancement Collection produced in our Parallel Synthesis Lab
  • Personalized, collaborative support using our Design and Computational
    Team to expedite specific chemical space exploration